Phase II study of nivolumab and salvage nivolumab plus ipilimumab in treatment-naive patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report.Michael B. Atkins,Opeyemi Jegede,Naomi B. Haas,David F. McDermott,Mehmet Asim Bilen,Mark N. Stein,Jeffrey Alan Sosman,Robert S. Alter,Elizabeth R. Plimack,Moshe Chaim Ornstein,Michael E. Hurwitz,David J. Peace,Sabina Signoretti,Thomas Denize,Alessia Cimadamore,David A. Braun,Catherine J. Wu,David Johnson Einstein,Paul J. Catalano,Hans J. HammersJOURNAL OF CLINICAL ONCOLOGY（2022）引用 14|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
